Ye Weiguo
CIK 1985496
Transactions on file
36
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-22 | 2026-06-18 | GYRE GYRE THERAPEUTICS, INC. | Chief Operating Officer | Sale | 3,000 | $19.1K | -11.2% | open → |
| 2026-06-22 | 2026-06-18 | GYRE GYRE THERAPEUTICS, INC. | Chief Operating Officer | Exer. | 3,000 | $2.3K | +652.0% | open → |
| 2026-06-22 | 2026-06-10 | GYRE GYRE THERAPEUTICS, INC. | Chief Operating Officer | Sale | 5,000 | $31.2K | -9.6% | open → |
| 2026-06-22 | 2026-06-10 | GYRE GYRE THERAPEUTICS, INC. | Chief Operating Officer | Exer. | 5,000 | $3.8K | +652.0% | open → |
| 2026-06-22 | 2026-06-09 | GYRE GYRE THERAPEUTICS, INC. | Chief Operating Officer | Sale | 3,000 | $18.4K | -8.3% | open → |
| 2026-06-22 | 2026-06-09 | GYRE GYRE THERAPEUTICS, INC. | Chief Operating Officer | Exer. | 3,000 | $2.3K | +652.0% | open → |
| 2026-06-15 | 2026-06-11 | GYRE GYRE THERAPEUTICS, INC. | Chief Operating Officer | Sale | 2,800 | $17.3K | -8.6% | open → |
| 2026-06-15 | 2026-06-11 | GYRE GYRE THERAPEUTICS, INC. | Chief Operating Officer | Exer. | 2,800 | $2.1K | +652.0% | open → |
| 2026-06-11 | 2026-06-10 | GYRE GYRE THERAPEUTICS, INC. | Chief Operating Officer | Sale | 6,418 | $39.9K | -9.2% | open → |
| 2026-06-11 | 2026-06-10 | GYRE GYRE THERAPEUTICS, INC. | Chief Operating Officer | Exer. | 6,418 | $4.8K | +652.0% | open → |
| 2026-06-11 | 2026-06-09 | GYRE GYRE THERAPEUTICS, INC. | Chief Operating Officer | Sale | 14,500 | $89.0K | -8.1% | open → |
| 2026-06-11 | 2026-06-09 | GYRE GYRE THERAPEUTICS, INC. | Chief Operating Officer | Exer. | 14,500 | $10.9K | +652.0% | open → |
| 2026-06-08 | 2026-06-05 | GYRE GYRE THERAPEUTICS, INC. | Chief Operating Officer | Sale | 15,401 | $98.6K | -11.9% | open → |
| 2026-06-08 | 2026-06-05 | GYRE GYRE THERAPEUTICS, INC. | Chief Operating Officer | Exer. | 15,401 | $11.6K | +652.0% | open → |
| 2026-06-08 | 2026-06-04 | GYRE GYRE THERAPEUTICS, INC. | Chief Operating Officer | Sale | 19,575 | $120.0K | -8.0% | open → |
| 2026-06-08 | 2026-06-04 | GYRE GYRE THERAPEUTICS, INC. | Chief Operating Officer | Exer. | 19,575 | $14.7K | +652.0% | open → |
| 2026-05-27 | 2026-05-26 | GYRE GYRE THERAPEUTICS, INC. | Chief Operating Officer | Sale | 4,000 | $24.4K | -7.5% | open → |
| 2026-05-27 | 2026-05-26 | GYRE GYRE THERAPEUTICS, INC. | Chief Operating Officer | Exer. | 4,000 | $3.0K | +652.0% | open → |
| 2026-05-27 | 2026-05-22 | GYRE GYRE THERAPEUTICS, INC. | Chief Operating Officer | Sale | 3,500 | $21.3K | -7.2% | open → |
| 2026-05-27 | 2026-05-22 | GYRE GYRE THERAPEUTICS, INC. | Chief Operating Officer | Exer. | 3,500 | $2.6K | +652.0% | open → |
| 2026-05-22 | 2026-05-21 | GYRE GYRE THERAPEUTICS, INC. | Chief Operating Officer | Sale | 12,820 | $78.8K | -8.3% | open → |
| 2026-05-22 | 2026-05-21 | GYRE GYRE THERAPEUTICS, INC. | Chief Operating Officer | Exer. | 12,820 | $9.6K | +652.0% | open → |
| 2026-05-22 | 2026-05-20 | GYRE GYRE THERAPEUTICS, INC. | Chief Operating Officer | Sale | 9,400 | $57.8K | -8.3% | open → |
| 2026-05-22 | 2026-05-20 | GYRE GYRE THERAPEUTICS, INC. | Chief Operating Officer | Exer. | 9,400 | $7.0K | +652.0% | open → |
| 2026-05-20 | 2026-05-19 | GYRE GYRE THERAPEUTICS, INC. | Chief Operating Officer | Sale | 9,120 | $58.1K | -11.5% | open → |
| 2026-05-20 | 2026-05-19 | GYRE GYRE THERAPEUTICS, INC. | Chief Operating Officer | Exer. | 9,120 | $6.8K | +652.0% | open → |
| 2026-05-20 | 2026-05-18 | GYRE GYRE THERAPEUTICS, INC. | Chief Operating Officer | Sale | 200 | $1.3K | -14.8% | open → |
| 2026-05-20 | 2026-05-18 | GYRE GYRE THERAPEUTICS, INC. | Chief Operating Officer | Exer. | 200 | $150.00 | +652.0% | open → |
| 2026-05-18 | 2026-05-15 | GYRE GYRE THERAPEUTICS, INC. | Chief Operating Officer | Sale | 13,100 | $87.1K | -15.2% | open → |
| 2026-05-18 | 2026-05-15 | GYRE GYRE THERAPEUTICS, INC. | Chief Operating Officer | Exer. | 13,100 | $9.8K | +652.0% | open → |
| 2026-05-18 | 2026-05-14 | GYRE GYRE THERAPEUTICS, INC. | Chief Operating Officer | Sale | 15,580 | $107.7K | -18.4% | open → |
| 2026-05-18 | 2026-05-14 | GYRE GYRE THERAPEUTICS, INC. | Chief Operating Officer | Exer. | 15,580 | $11.7K | +652.0% | open → |
| 2025-04-25 | 2025-03-24 | GYRE GYRE THERAPEUTICS, INC. | Officer Chief Operating Officer | Exer. | 300,000 | $225.0K | +652.0% | open → |
| 2025-04-25 | 2025-03-27 | GYRE GYRE THERAPEUTICS, INC. | Officer Chief Operating Officer | Exer. | 150,000 | $112.5K | +652.0% | open → |
| 2025-04-25 | 2025-03-26 | GYRE GYRE THERAPEUTICS, INC. | Officer Chief Operating Officer | Exer. | 200,000 | $150.0K | +652.0% | open → |
| 2025-05-14 | 2025-04-01 | GYRE GYRE THERAPEUTICS, INC. | Officer Chief Operating Officer | Exer. | 50,000 | $37.5K | +652.0% | open → |
